A phase II study of naloxone nasal spray for the treatment of cocaine use disorder

Trial Profile

A phase II study of naloxone nasal spray for the treatment of cocaine use disorder

Recruiting
Phase of Trial: Phase II

Latest Information Update: 23 Mar 2016

At a glance

  • Drugs Naloxone (Primary)
  • Indications Cocaine abuse
  • Focus Therapeutic Use
  • Sponsors Opiant Pharmaceuticals
  • Most Recent Events

    • 23 Mar 2016 New trial record
    • 16 Mar 2016 According to Opiant Pharmaceuticals media release, company plans to report top-line results by 1Q17.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top